G1 Therapeutics Announces Appointment of Andrew Perry as Chief Commercial Officer

NEXT STORY
OKYO Pharma Limited Announces final audited results for the year ended 31 March 2021
PREV STORY
Global Leukapheresis Market Size to Grow at a CAGR of 43.9% from 2021 to 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Castle Connolly Medical Ltd. Continues to Expand Its Database of Top Doctors Across the U.S.

New York, NY, May 15, 2018 (GLOBE NEWSWIRE) -- Castle Connolly Medical Ltd. (www.castleconnolly.com) ...

author_avatar
NASDAQ Market News

RedHill Biopharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

TEL-AVIV, Israel, Aug. 31, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” ...

author_avatar
NASDAQ Market News

Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April 2, 2018

DURHAM, N.C., March 28, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...

author_avatar
NASDAQ Market News